ICDMO's recombinant protein expression services deliver high-quality proteins for structural biology, drug target validation, antibody development, enzyme engineering, and biopharmaceutical manufacturing. Five orthogonal expression platforms operate in parallel, enabling our scientists to match the optimal system to each target based on size, glycosylation, disulfide bonds, and required quantity.
Our pipeline integrates codon optimization, vector engineering, fermentation or cell culture scale-up, and multi-step chromatography into a seamless one-stop service. Every batch undergoes rigorous QC before delivery.
Each system is maintained by dedicated protein scientists with platform-specific expertise.
Note: All services are for research use only unless specified as GMP. Contact us for IND-enabling or clinical manufacturing documentation.
Protein scientists respond within 24 hours with a feasibility assessment and detailed proposal.
Contact Us Online Consultation